Lori Hazlehurst

Lori Hazlehurst is a Professor of Pharmaceutical Sciences at West Virginia University, a position held since July 2015. In addition, Lori serves as President of Modulation Therapeutics since January 2011, where accomplishments include securing state technology transfer grants, a MMRF biotech investment award, and SBIR funding to advance a lead candidate towards IND filing. Prior to these roles, Lori was an Associate Member of Molecular Oncology at Moffitt Cancer Center from September 2003 to June 2015. Lori earned a Ph.D. in Cell and Molecular Biology from the University of Vermont and completed studies at Burke Mountain Academy High School.